Regulations.gov document
Appendix 2 - "Safety and Immunogenicity Assessment of Glatiramer Acetate Follow-on…
Supporting & Related Material · FDA-2010-P-0642 · posted Dec 17, 2010
Key facts
| Document ID | FDA-2010-P-0642-0004 |
|---|---|
| Title | Appendix 2 - "Safety and Immunogenicity Assessment of Glatiramer Acetate Follow-on Products (Glatiramoids)" [Teva Pharmaceutical Industries Ltd., Teva Neuroscience, Inc. Citizen Petition] |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2010-P-0642 |
| Posted | Dec 17, 2010 |
| Effective date | Dec 10, 2010 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: